VALBIOTIS Will Present the Results of the International Phase IIA Clinical Study of VALEDIA® before 31 July 2019
• The results of this study will evaluate the efficacy of VALEDIA® in prediabetic subjects for the first time •…
Pharmaceuticals, Biotechnology and Life Sciences
• The results of this study will evaluate the efficacy of VALEDIA® in prediabetic subjects for the first time •…
WASHINGTON–(BUSINESS WIRE)–Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases…
LEXINGTON, Mass. & NORTH CHICAGO, Ill.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AbbVie?src=hash" target="_blank"gt;#AbbVielt;/agt;–MC10, Inc., a healthcare technology company specializing in wearable digital health sensors,…
DUBLIN–(BUSINESS WIRE)–The “Vitamin C Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added…
INDIANAPOLIS–(BUSINESS WIRE)–Scioto Biosciences, a preclinical stage company developing next generation microbiome therapeutics, today announced that it will present at the…
Data-driven, proprietary approach powers a robust omnichannel platform to help pharmaceutical companies innovate their rare disease marketing efforts BOSTON–(BUSINESS WIRE)–Cambridge…
Updated data from Phase 1/2 ADXS-PSA study combination arm show prolonged survival in heavily pretreated prostate cancer patients with microsatellite-stable…
IRVING, Texas–(BUSINESS WIRE)–Vizient offered its formal endorsement of the Affordable Prescriptions for Patients Act. This bipartisan Senate legislation targets “patent thickets”…
Results of the Trial Suggest that ALG-1007 is Well-Tolerated and Demonstrates a Dose Response with Improvement as Early as Two…
Christine Bellon Appointed to Senior Vice President, Chief Legal Officer Susan O’Connor Appointed to Chief Human Resources Officer Suzanne Fleming…